Mechanical Circulatory Support and the Role of LVADs in Heart Failure Therapy
- PMID: 25983564
- PMCID: PMC4415686
- DOI: 10.4137/CMC.s19694
Mechanical Circulatory Support and the Role of LVADs in Heart Failure Therapy
Abstract
Heart failure is epidemic in the United States with a prevalence of over 5 million. The diagnosis carries a mortality risk of 50% at 5 years rivaling many diagnoses of cancer. Heart transplantation, long the "gold standard" treatment for end stage heart failure unresponsive to maximal medical therapy falls way short of meeting the need with only about 2,000 transplants performed annually in the United States due to donor limitation. Left ventricular devices have emerged as a viable option for patients as both a "bridge to transplantation" and as a final "destination therapy".
Keywords: heart failure; mechanical circulatory support; ventricular assist device.
References
-
- Levy D, Kenchaiah S, Larson MG, et al. Long term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–402. - PubMed
-
- Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long term survival after heart failure: a contemporary population based perspective. Arch Intern Med. 2007;167:490–6. - PubMed
-
- The International Society for Heart and Lung Transplantation Heart/Lung Registries: Quarterly Data Report. 2014. Available at: http://www.ishlt.org/registries/quarterlyDataReport.asp.
Publication types
LinkOut - more resources
Full Text Sources
